ClinicalTrials.Veeva

Menu
M

Marietta Eye Clinic | Marietta, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

JNJ-81201887
Sirolimus
RG7774
THR-149
Fluocinolone Acetonide
Aflibercept
DE-109
Triamcinolone Acetonide
ONL1204
Abicipar Pegol

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 22 total trials

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to assess the long-term safety and tolerability after an intravitreal injection (a shot of medicine into the eye) of JNJ...

Enrolling
Macular Degeneration
Geographic Atrophy
Other: Sham Procedure
Drug: JNJ-81201887

The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.

Active, not recruiting
Geographic Atrophy
Drug: Triamcinolone
Other: Sham Procedure

Researchers are looking for a better way to treat people who have macular edema secondary to retinal vein occlusion (RVO).In people with RVO, a blood...

Active, not recruiting
Macular Edema Secondary to Retinal Vein Occlusion
Drug: Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_2 mg
Drug: Sham
Recently updated

This is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will...

Enrolling
Myopia
Myopia Progression
Device: Single vision, impact-resistant spectacle lenses; Test Arm
Device: Single vision, impact-resistant spectacle lenses; Control Arm

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 y...

Enrolling
Diabetic Retinopathy
Other: Placebo
Drug: Fenofibrate

A study to evaluate the safety and efficacy of YUTIQ® 0.18 mg intravitreal implant for the management of chronic non-infectious posterior segment uve...

Active, not recruiting
Uveitis, Posterior
Drug: Fluocinolone Acetonide Intravitreal Implant 0.18 mg

The VOYAGE trial will assess diabetic retinopathy severity scale (DRSS) levels, through 112 weeks, while being managed with aflibercept as needed, am...

Active, not recruiting
Diabetic Retinopathy
Drug: Aflibercept Injection

Trial sponsors

C
Jaeb Center for Health Research logo
Janssen (J&J Innovative Medicine) logo
A
Allergan logo
Bayer logo
O
Oxurion logo
Roche logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems